Horizon Therapeutics Public Limited Company (HZNP)

1 member of Congress has disclosed 2 trades in Horizon Therapeutics Public Limited Company (HZNP) via STOCK Act filings. The most recent disclosure was a sale by Greg Landsman on 3 February 2023. Aggregate disclosed activity totals roughly $16K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for HZNP
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for HZNP

2 transactions
Compliance: 0%
Greg Landsman3 Feb 202314 Aug 2024SaleStock$1,001 - $15,000N/A
Greg Landsman3 Feb 202324 Jan 2025SaleStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$26.6B

Volume

23.92M

Beta

1.01

P/E Ratio

61.86

Fundamentals

EPS

$1.88

Div. Yield

-

Open

$116.34

Day Range

$116.30 – $116.34

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ · USD
Country
IE
CEO
Timothy P. Walbert
IPO Date
2011-07-28
Website
www.amgen.com

Horizon Therapeutics Public Limited Company operates as a biotechnology enterprise, primarily concentrating on the identification, refinement, and commercialization of pharmaceutical products designed to address significant medical needs for individu...

Earnings

Recent Quarters

Q3 20231 Nov
EPS$1.25
Beat 2.5%
Q2 20238 Aug
EPS$1.20
Beat 7.1%
Q1 20233 May
EPS$0.83
Miss 29.1%
Q4 20221 Mar
EPS$1.21
Beat 11.0%
Q3 20222 Nov
EPS$1.25
Beat 25.0%
Q2 20223 Aug
EPS$1.07
Miss 20.7%
Q1 20224 May
EPS$1.34
Beat 16.5%
Q4 20211 Mar
EPS$1.41
Beat 11.0%
Q3 20213 Nov
EPS$1.75
Beat 13.6%
Q2 20214 Aug
EPS$1.62
Beat 78.0%
Q1 20215 May
EPS$0.03
Miss 57.1%
Q4 202024 Feb
EPS$1.28
Beat 21.9%
Q3 20202 Nov
EPS$1.74
Beat 79.4%
Q2 20205 Aug
EPS$0.43
Beat 7.5%
Q1 20206 May
EPS$0.44
Beat 91.3%
Q4 201926 Feb
EPS$0.56
Beat 30.2%
Q3 20196 Nov
EPS$0.64
Beat 25.5%
Q2 20197 Aug
EPS$0.49
Beat 28.9%
Q1 20198 May
EPS$0.30
Beat 200.0%
Q4 201827 Feb
EPS$0.67
Beat 24.1%
Q3 20187 Nov
EPS$0.65
Beat 30.0%
Q2 20188 Aug
EPS$0.48
Beat 65.5%
Q1 20189 May
EPS$0.03
Miss 72.7%
Q4 201728 Feb
EPS$0.29
Beat 31.8%
Q3 20176 Nov
EPS$0.26
Beat 18.2%
Q2 20177 Aug
EPS$0.41
Beat 241.7%
Q1 20178 May
EPS$0.21
Miss 16.0%
Q4 201627 Feb
EPS$0.66
Beat 26.9%
Q3 20167 Nov
EPS$0.70
Beat 11.1%
Q2 20168 Aug
EPS$0.56
Beat 5.7%
Q1 20169 May
EPS$0.34
Miss 10.5%
Q4 201529 Feb
EPS$0.63
Miss 4.5%
Q3 20156 Nov
EPS$0.72
Beat 60.0%
Q2 20157 Aug
EPS$0.39
Beat 39.3%
Q1 20158 May
EPS$0.21
Miss 4.5%
Q4 201427 Feb
EPS$0.30
Beat 30.4%
Q3 20146 Nov
EPS$0.24
Beat 26.3%
Q2 20147 Aug
EPS$0.21
Beat 110.0%
Q1 20149 May
EPS$0.13
Beat 62.5%
Q4 201313 Mar
EPS$-0.22
Miss 266.7%
Q3 20138 Nov
EPS$-0.03
Beat 88.5%
Q2 20139 Aug
EPS$-0.24
Beat 14.3%
Q1 201310 May
EPS$-0.30
Beat 9.1%
Q4 201218 Mar
EPS$-0.34
Beat 30.6%
Q3 201213 Nov
EPS$-0.39
Beat 33.9%
Q2 201210 Aug
EPS$-0.62
Beat 6.1%
Q1 201210 May
EPS$-0.85
Beat 7.6%
Q4 201123 Mar
EPS$-0.97
Beat 19.2%
Q3 201114 Nov
EPS$-1.18
Miss 25.5%
Q1 201130 Jun
EPS$-7.78
Q4 201031 Mar
EPS$-5.13
Q3 201031 Dec
EPS$-5.89
Q2 201030 Sept
EPS$-8.38
Q1 201030 Jun
EPS$0.56
Q4 200931 Mar
EPS$-5.28
Q3 200931 Dec
EPS$-3.84
Q2 200930 Sept
EPS$-3.33
Q1 200930 Jun
EPS$-3.39
Q4 200831 Mar
EPS$-3.14

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about HZNP

Which members of Congress have traded HZNP?
1 member of Congress has disclosed 2 trade in Horizon Therapeutics Public Limited Company (HZNP) under the STOCK Act: Greg Landsman.
When was HZNP most recently disclosed by Congress?
The most recent HZNP disclosure was a sale by Greg Landsman on 3 February 2023.
What is the total disclosed congressional trading volume for HZNP?
Members of Congress have disclosed approximately $16K in HZNP sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in HZNP?
This HZNP page updates as soon as new STOCK Act disclosures are filed for Horizon Therapeutics Public Limited Company. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.